Trial Profile
Randomized controlled clinical trials on the therapeutic effects of triamcinolone acetonide versus bevacizumab for diabetic macular edema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 27 Nov 2015 Status changed from recruiting to completed according to Results published in the Investigative Ophthalmology and Visual Science
- 31 Jan 2013 Status changed from not stated to recruiting.
- 31 Jan 2013 New trial record